Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Takamatsu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Nephrology. Case Studies|November 18, 2021
COVID-19 and renal infarct: To be or not to be on anticoagulationChelsea Takamatsu, Paola Devis, Ramin Tolouian
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 17, 2023
KCCQ total symptom score, clinical outcome measures, and adverse events associated with omecamtiv mecarbil for heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trialsRamzi Ibrahim, Abdulbaril Olagunju, Kristina Terrani, et al.
Plos One|January 26, 2024
County-level variation in healthcare coverage and ischemic heart disease mortalityRamzi Ibrahim, Adam Habib, Kristina Terrani, et al.
JACC. Advances|June 28, 2024
Impact of Social Vulnerability and Demographics on Ischemic Heart Disease Mortality in the United StatesRamzi Ibrahim, Mohammed Salih, Coco Victoria Gomez Tirambulo, et al.
Journal of Cardiac Failure|October 25, 2024
Kidney Replacement Therapies in Advanced Heart Failure: Timing, Modalities and Clinical ConsiderationsRamzi Ibrahim, Chelsea Takamatsu, Abdulla Alabagi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Nephrology. Case Studies|November 18, 2021
COVID-19 and renal infarct: To be or not to be on anticoagulationChelsea Takamatsu, Paola Devis, Ramin Tolouian
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 17, 2023
KCCQ total symptom score, clinical outcome measures, and adverse events associated with omecamtiv mecarbil for heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trialsRamzi Ibrahim, Abdulbaril Olagunju, Kristina Terrani, et al.
Plos One|January 26, 2024
County-level variation in healthcare coverage and ischemic heart disease mortalityRamzi Ibrahim, Adam Habib, Kristina Terrani, et al.
JACC. Advances|June 28, 2024
Impact of Social Vulnerability and Demographics on Ischemic Heart Disease Mortality in the United StatesRamzi Ibrahim, Mohammed Salih, Coco Victoria Gomez Tirambulo, et al.
Journal of Cardiac Failure|October 25, 2024
Kidney Replacement Therapies in Advanced Heart Failure: Timing, Modalities and Clinical ConsiderationsRamzi Ibrahim, Chelsea Takamatsu, Abdulla Alabagi, et al.
Pageof 1